The Future of Psychedelic Medicine
Our Story
Find out what inspires us to support mental health disorders.
Our Mission
Supporting innovative therapies to help humans thrive.
Our Team
Multi-Disciplinary Collaboration
creating positive experiences and outcomes.
Mission
Using a foundation of evidence-informed research, we want to empower people to achieve their potential and thrive.
CORE PILLARS
HAVN Labs
- Havn Labs will support innovative therapies addressing human health through the development of methods for standardization and the extraction of quality-controlled compounds derived from plants and fungi.
Psychedelic medicine is the frontier of mental health and wellness
Social attitudes and behaviours towards mental health are shifting away from pharmaceuticals in favour of sustainably resourced compounds derived from fungi and plant medicines.
350 Million
People globally are affected by a form of depression.
1 Trillion
Dollars lost annually in global workforce productivity due to depression and anxiety.
0
Formulas standardized across clinical studies of psychedelic compounds.
Havn Life is part of a global community taking an active role in formulations and research for microdosing therapies which have shown effectiveness in addressing mental health and performance.
Havn Life Completes Acquisition of Strategic Manufacturing & Packaging Facility for its Retail Division
The Facility acquisition positions Havn Life to quickly expand its product portfolio and reach additional NHP categories. Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) …
Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness
Havn Life believes operations can advance its business plan and potentially accelerate production of naturally-derived psilocybin for global medical research. Vancouver, BC – Havn Life …
Havn Life CEO to Present at Zooming With LD, a Leading Platform for Microcap Companies
CEO Tim Moore will appear on Tuesday, March 24th at 8:00 AM PT/ 11:00 AM ET Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) …